Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by garygpon Oct 20, 2014 1:22pm
179 Views
Post# 23043939

RE:RE:New study out using Ventripoint

RE:RE:New study out using Ventripointsr; Agree wholeheartedly with your post and I'll go one step further and add it's time for a leadership review and the ousting of George Adams. He (Adam's), brings no value at any level IMO, has diluted shareholders by a factor or 2 or more, and his 225,000 dollar annual salary plus perks for what he has provided or accomplished is laughable. You spoke of a business plan for the company....that's exactly what Adam's was tasked with 5 years ago to do, and has failed to provide. This is what current management is so desperately attempting to do now. We are behind in the market by 3 years from where we should be. It's time Adam's was shown the door, and soon. In my next post, I'll let you know what I really think. Gary.
Bullboard Posts